221 related articles for article (PubMed ID: 27164273)
1. Pragmatic trial design elements showed a different impact on trial interpretation and feasibility than explanatory elements.
Nieuwenhuis JB; Irving E; Oude Rengerink K; Lloyd E; Goetz I; Grobbee DE; Stolk P; Groenwold RH; Zuidgeest MG;
J Clin Epidemiol; 2016 Sep; 77():95-100. PubMed ID: 27164273
[TBL] [Abstract][Full Text] [Related]
2. Explanatory Versus Pragmatic Trials: An Essential Concept in Study Design and Interpretation.
Merali Z; Wilson JR
Clin Spine Surg; 2017 Nov; 30(9):404-406. PubMed ID: 29049130
[TBL] [Abstract][Full Text] [Related]
3. Series: Pragmatic trials and real world evidence: Paper 1. Introduction.
Zuidgeest MGP; Goetz I; Groenwold RHH; Irving E; van Thiel GJMW; Grobbee DE;
J Clin Epidemiol; 2017 Aug; 88():7-13. PubMed ID: 28549929
[TBL] [Abstract][Full Text] [Related]
4. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.
Godwin M; Ruhland L; Casson I; MacDonald S; Delva D; Birtwhistle R; Lam M; Seguin R
BMC Med Res Methodol; 2003 Dec; 3():28. PubMed ID: 14690550
[TBL] [Abstract][Full Text] [Related]
5. Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trial.
Dal-Ré R
J Eval Clin Pract; 2018 Feb; 24(1):258-261. PubMed ID: 28685913
[TBL] [Abstract][Full Text] [Related]
6. A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.
Palmer JA; Mor V; Volandes AE; McCreedy E; Loomer L; Carter P; Dvorchak F; Mitchell SL
Trials; 2018 Aug; 19(1):453. PubMed ID: 30134976
[TBL] [Abstract][Full Text] [Related]
7. Validation of the GetReal Trial Tool - Facilitating discussion and understanding more pragmatic design choices and their implications.
Boateng D; Kumke T; Vernooij R; Goetz I; Meinecke AK; Steenhuis C; Grobbee D; Zuidgeest MGP;
Contemp Clin Trials; 2023 Feb; 125():107054. PubMed ID: 36529438
[TBL] [Abstract][Full Text] [Related]
8. Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty.
Chan CL; Taljaard M; Lancaster GA; Brehaut JC; Eldridge SM
J Clin Epidemiol; 2021 Oct; 138():102-114. PubMed ID: 34229091
[TBL] [Abstract][Full Text] [Related]
9. How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial.
Selby P; Brosky G; Oh PI; Raymond V; Ranger S
BMC Med Res Methodol; 2012 Jul; 12():101. PubMed ID: 22824225
[TBL] [Abstract][Full Text] [Related]
10. The GetReal Trial Tool: design, assess and discuss clinical drug trials in light of Real World Evidence generation.
Zuidgeest MGP; Goetz I; Meinecke AK; Boateng D; Irving EA; van Thiel GJM; Welsing PMJ; Oude-Rengerink K; Grobbee DE;
J Clin Epidemiol; 2022 Sep; 149():244-253. PubMed ID: 34929319
[TBL] [Abstract][Full Text] [Related]
11. Series: Pragmatic trials and real world evidence: Paper 6. Outcome measures in the real world.
Welsing PM; Oude Rengerink K; Collier S; Eckert L; van Smeden M; Ciaglia A; Nachbaur G; Trelle S; Taylor AJ; Egger M; Goetz I;
J Clin Epidemiol; 2017 Oct; 90():99-107. PubMed ID: 28502810
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
Mansouri A; Cooper B; Shin SM; Kondziolka D
J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
[TBL] [Abstract][Full Text] [Related]
13. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.
Thorpe KE; Zwarenstein M; Oxman AD; Treweek S; Furberg CD; Altman DG; Tunis S; Bergel E; Harvey I; Magid DJ; Chalkidou K
J Clin Epidemiol; 2009 May; 62(5):464-75. PubMed ID: 19348971
[TBL] [Abstract][Full Text] [Related]
14. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?
Dal-Ré R; Janiaud P; Ioannidis JPA
BMC Med; 2018 Apr; 16(1):49. PubMed ID: 29615035
[TBL] [Abstract][Full Text] [Related]
15. Pragmatic trials in primary care. Methodological challenges and solutions demonstrated by the DIAMOND-study.
Fransen GA; van Marrewijk CJ; Mujakovic S; Muris JW; Laheij RJ; Numans ME; de Wit NJ; Samsom M; Jansen JB; Knottnerus JA
BMC Med Res Methodol; 2007 Apr; 7():16. PubMed ID: 17451599
[TBL] [Abstract][Full Text] [Related]
16. Study control, violators, inclusion criteria and defining explanatory and pragmatic trials.
McMahon AD
Stat Med; 2002 May; 21(10):1365-76. PubMed ID: 12185890
[TBL] [Abstract][Full Text] [Related]
17. How study designs influence comparative effectiveness outcomes: the case of oral versus long-acting injectable antipsychotic treatments for schizophrenia.
Alphs L; Schooler N; Lauriello J
Schizophr Res; 2014 Jul; 156(2-3):228-32. PubMed ID: 24842538
[TBL] [Abstract][Full Text] [Related]
18. Informing real-world practice with real-world evidence: the value of PRECIS-2.
Neta G; Johnson KE
BMC Med; 2018 May; 16(1):76. PubMed ID: 29783964
[TBL] [Abstract][Full Text] [Related]
19. [Progress in research of pragmatic-explanatory continuum indicator summary].
Hu G; Hu Y; Zhan S
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):439-42. PubMed ID: 27005554
[TBL] [Abstract][Full Text] [Related]
20. The Social Value of Pragmatic Trials.
Kalkman S; van Thiel G; van der Graaf R; Zuidgeest M; Goetz I; Grobbee D; van Delden J
Bioethics; 2017 Feb; 31(2):136-143. PubMed ID: 28060433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
